US Patent Issued to COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES on April 7 for "Vasopressin-2 receptor antagonist peptides and uses thereof" (French Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,288, issued on April 7, was assigned to COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (Paris).

"Vasopressin-2 receptor antagonist peptides and uses thereof" was invented by Nicolas Gilles (Gif sur Yvette, France), Justyna Ciolek (Coignieres, France), Laura Droctove (Paris), Bernard Maillere (Gif sur Yvette, France) and Herve Nozach (Gif sur Yvette, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "A peptide may include a sequence having 80% or more amino acid identity with the amino acid sequence of SEQ ID NO. 1, i.e., RPSX1CNLPVKPGPCX2GFFSAFYYSQKX3NKCHSFTYGGCAGNANRFSTX4EKCRRTC X5X6, wherein, X1 is the amino acid residue F or G,...